Stock Events

Stock Events

Moberg Pharma AB 

$1.1000
10
+$0.05+4.76% Tuesday 19:17

Statistics

Day High
1.1
Day Low
1.1
52W High
1.2
52W Low
0.82
Volume
5,000
Avg. Volume
145
Mkt Cap
54.23M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

12NovExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
-0.01
-0.01
-0
0
Expected EPS
N/A
Actual EPS
N/A

Financials

-204.84%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
1.42MRevenue
-2.9MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson operates in the pharmaceuticals sector, offering a wide range of healthcare products that compete with Moberg Pharma's offerings.
Pfizer
PFE
Mkt Cap159.36B
Pfizer is a global biopharmaceutical company with a portfolio that includes treatments in areas similar to those targeted by Moberg Pharma.
Novartis
NVS
Mkt Cap292.35B
Novartis is a multinational pharmaceutical company that produces drugs in many of the same categories as Moberg Pharma.
GSK
GSK
Mkt Cap101.78B
GlaxoSmithKline is a healthcare company that develops and markets drugs and vaccines in various areas, including those competing with Moberg Pharma.
Merck
MRK
Mkt Cap366B
Merck & Co., Inc. is a global healthcare company that offers products in areas that overlap with Moberg Pharma's therapeutic focus.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie is a biopharmaceutical company with a broad range of medical products that compete in the same market as Moberg Pharma.
Sanofi
SNY
Mkt Cap107.39B
Sanofi is a global healthcare leader that offers drugs in many of the same therapeutic areas as Moberg Pharma.
AMGEN
AMGN
Mkt Cap233.78B
Amgen is a biotechnology company focused on developing novel treatments, some of which compete with Moberg Pharma's products.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap42.46B
Teva Pharmaceutical Industries is a global leader in generic and specialty medicines, competing directly in some of the markets targeted by Moberg Pharma.

About

Moberg Pharma AB (publ) functions as a pharmaceutical company, dedicated to both crafting and globally marketing medical solutions throughout Europe, the United States, and various international territories. A notable product within its development portfolio is MOB-015, a treatment designed for nail fungus, which has successfully concluded its Phase III clinical trials. Established in 2006, this enterprise is headquartered in Bromma, Sweden. It was previously known as Moberg Derma AB (publ) until its rebranding to the current name in May 2013.
Show more...
CEO
Ms. Anna Ljung BA, M.Sc.
Employees
5
Country
Sweden
ISIN
SE0020353928
WKN
000A3EGXK

Listings

STU
DE
MB8.STU
MU
DE
MB8A.MU
MU
DE
MB8.MU
F
DE
MB8.F

0 Comments

Share your thoughts

FAQ

What is Moberg Pharma AB stock price today?▼
The current price of MBGPF is $1.10 USD — it has increased by +4.76% in the past 24 hours. Watch Moberg Pharma AB stock price performance more closely on the chart.
What is Moberg Pharma AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Moberg Pharma AB stocks are traded under the ticker MBGPF.
Is Moberg Pharma AB stock price growing?▼
MBGPF stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Moberg Pharma AB has showed a +4.76% increase.
What is Moberg Pharma AB market cap?▼
Today Moberg Pharma AB has the market capitalization of 54.23M
When is the next Moberg Pharma AB earnings date?▼
Moberg Pharma AB is going to release the next earnings report on November 12, 2026.
What is Moberg Pharma AB revenue for the last year?▼
Moberg Pharma AB revenue for the last year amounts to 1.42M USD.
What is Moberg Pharma AB net income for the last year?▼
MBGPF net income for the last year is -2.9M USD.
How many employees does Moberg Pharma AB have?▼
As of September 04, 2026, the company has 5 employees.
In which sector is Moberg Pharma AB located?▼
Moberg Pharma AB operates in the Other sector.
When did Moberg Pharma AB complete a stock split?▼
Moberg Pharma AB has not had any recent stock splits.
Where is Moberg Pharma AB headquartered?▼
Moberg Pharma AB is headquartered in Bromma, Sweden.